Europe - BIT:1LONN - CH0013841017 - Common Stock
The current stock price of 1LONN.MI is 565 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 25.51 | 181.65B | ||
1TMO.MI | THERMO FISHER SCIENTIFIC INC | 24.15 | 171.96B | ||
DAP.DE | DANAHER CORP | 28.97 | 134.63B | ||
1DHR.MI | DANAHER CORP | 27.36 | 127.14B | ||
LO3.DE | LONZA GROUP AG-REG | 35.65 | 42.04B | ||
QTS.DE | IQVIA HOLDINGS INC | 18.93 | 31.80B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 60.4 | 20.58B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 60.63 | 20.65B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 52.64 | 17.97B | ||
SRT.DE | SARTORIUS AG | 42.5 | 14.51B | ||
ILU.DE | ILLUMINA INC | 23.89 | 13.15B | ||
ERF.PA | EUROFINS SCIENTIFIC | 17.53 | 11.49B |
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 19,299 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
LONZA GROUP AG-REG
Muenchensteinerstrasse 38
Basel BASEL-STADT CH
Employees: 19299
Phone: 41613168111
The current stock price of 1LONN.MI is 565 EUR.
The exchange symbol of LONZA GROUP AG-REG is 1LONN and it is listed on the Euronext Milan exchange.
1LONN.MI stock is listed on the Euronext Milan exchange.
LONZA GROUP AG-REG (1LONN.MI) has a market capitalization of 39.68B EUR. This makes 1LONN.MI a Large Cap stock.
LONZA GROUP AG-REG (1LONN.MI) currently has 19299 employees.
The Revenue of LONZA GROUP AG-REG (1LONN.MI) is expected to grow by 14.55% in the next year. Check the estimates tab for more information on the 1LONN.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LONZA GROUP AG-REG (1LONN.MI) has a dividend yield of 0.73%. The yearly dividend amount is currently 4.31. Check the full fundamental report for a detailed analysis of 1LONN.MI dividend history, reliability and sustainability.
LONZA GROUP AG-REG (1LONN.MI) will report earnings on 2026-01-27, after the market close.
The PE ratio for LONZA GROUP AG-REG (1LONN.MI) is 33.65. This is based on the reported non-GAAP earnings per share of 16.79 and the current share price of 565 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1LONN.MI.
ChartMill assigns a technical rating of 1 / 10 to 1LONN.MI.
ChartMill assigns a fundamental rating of 5 / 10 to 1LONN.MI. 1LONN.MI has only an average score on both its financial health and profitability.
Over the last trailing twelve months 1LONN.MI reported a non-GAAP Earnings per Share(EPS) of 16.79. The EPS increased by 16.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.33% | ||
ROA | 4.1% | ||
ROE | 7.84% | ||
Debt/Equity | 0.39 |
For the next year, analysts expect an EPS growth of 11.86% and a revenue growth 14.55% for 1LONN.MI